Results 31 to 40 of about 41,569 (168)

An analysis of the cultivation, consumption and composition of home-grown cannabis following decriminalisation in the Australian Capital Territory

Scientific Reports
The Australian Capital Territory (ACT), a region that includes Australia’s capital, Canberra, decriminalised small-scale cannabis cultivation and possession in January 2020.
Cilla Zhou, Isobel Lavender, Rebecca Gordon, Danielle McCartney, Richard C. Kevin, Miguel A. Bedoya-Pérez, Iain S. McGregor   +6 more
doaj   +1 more source

Effects of Two Cannabidiol Oil Products on Self-Reported Stress Relief: A Quasi-Experimental Study

Medical Cannabis and Cannabinoids, 2023
Introduction: Estimated rates of past-month cannabidiol (CBD) use in the general public are 13–26% and emerging research examines CBD as a potential adjunct treatment for several medical conditions, including stress-related disorders (e.g., depression ...
Mohammed Faraj, Tyler Dautrich, Leslie Lundahl, Hilary Marusak   +3 more
doaj   +1 more source

Cannabinoids and Pain [PDF]

Pain Research and Management, 2001
Cannabinoids have been used to treat pain for many centuries. However, only during the past several decades have rigorous scientific methods been applied to understand the mechanisms of cannabinoid action. Cannabinoid receptors were discovered in the late 1980s and have been found to mediate the effects of cannabinoids on the nervous system.
J Michael Walker, Nicole M Strangman, Susan M Huang   +2 more
openaire   +3 more sources

Dosage Related Efficacy and Tolerability of Cannabidiol in Children With Treatment-Resistant Epileptic Encephalopathy: Preliminary Results of the CARE-E Study

Frontiers in Neurology, 2019
Purpose: There is uncertainty regarding the appropriate dose of Cannabidiol (CBD) for childhood epilepsy. We present the preliminary data of seven participants from the Cannabidiol in Children with Refractory Epileptic Encephalopathy (CARE-E) study ...
Richard J. Huntsman, Richard J. Huntsman, Richard Tang-Wai, Richard Tang-Wai, Jane Alcorn, Jane Alcorn, Stephanie Vuong, Bryan Acton, Bryan Acton, Scott Corley, Scott Corley, Robert Laprairie, Robert Laprairie, Andrew W. Lyon, Andrew W. Lyon, Simona Meier, Darrell D. Mousseau, Darrell D. Mousseau, Doris Newmeyer, Erin Prosser-Loose, Blair Seifert, Blair Seifert, Jose Tellez-Zenteno, Jose Tellez-Zenteno, Linda Huh, Edward Leung, Philippe Major   +26 more
doaj   +1 more source

Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review

Biology, 2022
Cannabis sativa L. (Cannabis) and its bioactive compounds, including cannabinoids and non-cannabinoids, have been extensively studied for their biological effects in recent decades. Cannabidiol (CBD), a major non-intoxicating cannabinoid in Cannabis, has
Camren G. Heider, Sasha A. Itenberg, Jiajia Rao, Hang Ma, Xian Wu   +4 more
doaj   +1 more source

Nightmares and the Cannabinoids [PDF]

Current Neuropharmacology, 2020
:The cannabinoids, Δ9 tetrahydrocannabinol and its analogue, nabilone, have been found to reliably attenuate the intensity and frequency of post-traumatic nightmares. This essay examines how a traumatic event is captured in the mind, after just a single exposure, and repeatedly replicated during the nights that follow.
openaire   +2 more sources

Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022–2023 (CAMS-22)

Harm Reduction Journal
Background Cannabis was legalised for medical purposes in 2016. Uptake was initially slow, but since 2019 there has been a large increase in the number of Australians who have been prescribed cannabis for medical reasons.
Llewellyn Mills, Jonathon C. Arnold, Anastasia Suraev, Sarah V. Abelev, Cilla Zhou, Thomas R. Arkell, Iain S. McGregor, Nicholas Lintzeris   +7 more
doaj   +1 more source

Cannabinoid combination targets NOTCH1-mutated T-cell acute lymphoblastic leukemia through the integrated stress response pathway

eLife
In T-cell acute lymphoblastic leukemia (T-ALL), more than 50% of cases display autoactivation of Notch1 signaling, leading to oncogenic transformation.
Elazar Besser, Anat Gelfand, Shiri Procaccia, Paula Berman, David Meiri   +4 more
doaj   +1 more source

Cannabinoids for fibromyalgia [PDF]

Cochrane Database of Systematic Reviews, 2016
This review is one of a series on drugs used to treat fibromyalgia. Fibromyalgia is a clinically well-defined chronic condition of unknown aetiology characterised by chronic widespread pain that often co-exists with sleep problems and fatigue affecting approximately 2% of the general population.
Walitt, Brian, Klose, Petra, Fitzcharles, Mary-Ann, Phillips, Tudor, Häuser, Winfried   +4 more
openaire   +3 more sources

A Discount on Cannabinoids

Biological Psychiatry, 2014
Signs posted in coffee shops throughout California warn their readers that “chemicals known to cause cancer and reproductive toxicity are present in coffee, baked goods and other foods or beverages sold here.” Undeterred by the admonition, every day millions of Californians eat their morning muffin accompanied by a hefty coffee drink.
openaire   +4 more sources